What is Bristol-Myers Squibb’s policy on transparency?
Bristol-Myers Squibb supports the goal of providing transparency of the scope and nature of interactions between biopharmaceutical companies and organizations, including patient advocacy organizations that provide and purchase health care on behalf of the U.S. population. It is critical that health care decisions be based solely on what is best for patients – considering the best evidence that will enable the highest quality of health care delivery to optimize patient outcomes.
